Myocardial cell hypertrophy after myocardial infarction with reperfusion in dogs

M Kambayashi1, T Miura, B H Oh

  • 1Kyoto University Hospital, Japan.

Circulation
|December 11, 1992
PubMed

Insights

Myocardial infarction recovery involves cellular hypertrophy in surviving heart cells. This study found larger cell sizes in the infarcted posterior wall and endocardial regions, suggesting a role in functional recovery after reperfusion.

Area of Science:

  • Cardiovascular Physiology
  • Cardiac Remodeling
  • Myocardial Infarction Research

Background:

  • The role of myocardial cell hypertrophy in the recovery of contractile function after myocardial infarction (MI) and reperfusion is not well understood.
  • Investigating cellular changes in the ischemic zone is crucial for understanding long-term cardiac function post-MI.

Purpose of the Study:

  • To examine the potential role of myocardial cell hypertrophy in the ischemic zone in the mechanism of late recovery of regional contractile function after myocardial infarction followed by reperfusion.
  • To quantify changes in myocardial cell size in different regions of the heart after infarction and reperfusion.

Main Methods:

  • Eight dogs underwent coronary artery occlusion followed by reperfusion.
  • Ultrasonic gauges measured wall thickness and function of anterior (AT) and posterior (PT) walls.
  • Cross-sectional areas of myocardial cells were determined in subepicardial, midwall, and subendocardial regions three weeks post-reperfusion.

Main Results:

  • The posterior wall (PT) showed dyskinesia during occlusion but recovered function post-reperfusion.
  • Cross-sectional areas of myocardial cells in the infarcted PT wall were significantly larger than in control dogs.
  • Cellular hypertrophy was observed in the endocardial regions of both infarcted and non-infarcted walls.

Conclusions:

  • Myocardial infarction followed by reperfusion leads to significant cellular hypertrophy in the infarcted wall, particularly in the endocardial region.
  • Hypertrophy of surviving myocardial cells in the infarcted zone may contribute to the late recovery of regional contractile function.
  • These findings highlight cellular remodeling as a key component of cardiac adaptation after ischemic injury.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...